Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo.

Literature DB >> 28117345

A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo.

Chao Jiang¹, Miao Mei¹, Bin Li², Xiurui Zhu³, Wenhong Zu¹, Yujie Tian¹, Qiannan Wang¹, Yong Guo³, Yizhou Dong², Xu Tan¹.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2017 PMID： 28117345 PMCID： PMC5339835 DOI： 10.1038/cr.2017.16

Source DB: PubMed Journal: Cell Res ISSN： 1001-0602 Impact factor: 25.617

× No keyword cloud information.

15 in total

1. Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome.

Authors: Xing Liu; Ruidong Hao; Shuliang Chen; Deyin Guo; Yu Chen
Journal: J Gen Virol Date: 2015-04-22 Impact factor: 3.891

2. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.

Authors: Chunsheng Dong; Liang Qu; Haoyi Wang; Lin Wei; Yuansu Dong; Sidong Xiong
Journal: Antiviral Res Date: 2015-04-03 Impact factor: 5.970

Review 3. Targeting hepatitis B virus cccDNA using CRISPR/Cas9.

Authors: Edward M Kennedy; Anand V R Kornepati; Bryan R Cullen
Journal: Antiviral Res Date: 2015-10-22 Impact factor: 5.970

4. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection.

Authors: Priscilla L Yang; Alana Althage; Josan Chung; Francis V Chisari
Journal: Proc Natl Acad Sci U S A Date: 2002-10-08 Impact factor: 11.205

5. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice.

Authors: Zhihua Qi; Gaiyun Li; Hao Hu; Chunhui Yang; Xiaoming Zhang; Qibin Leng; Youhua Xie; Demin Yu; Xinxin Zhang; Yueqiu Gao; Ke Lan; Qiang Deng
Journal: J Virol Date: 2014-05-07 Impact factor: 5.103

6. An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo.

Authors: Bin Li; Xiao Luo; Binbin Deng; Junfeng Wang; David W McComb; Yimin Shi; Karin M L Gaensler; Xu Tan; Amy L Dunn; Bryce A Kerlin; Yizhou Dong
Journal: Nano Lett Date: 2015-11-06 Impact factor: 11.189

7. The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo.

Authors: Su-Ru Lin; Hung-Chih Yang; Yi-Ting Kuo; Chun-Jen Liu; Ta-Yu Yang; Ku-Chun Sung; You-Yu Lin; Hurng-Yi Wang; Chih-Chiang Wang; Yueh-Chi Shen; Fang-Yi Wu; Jia-Horng Kao; Ding-Shinn Chen; Pei-Jer Chen
Journal: Mol Ther Nucleic Acids Date: 2014-08-19 Impact factor: 10.183

8. In vivo genome editing using Staphylococcus aureus Cas9.

Authors: F Ann Ran; Le Cong; Winston X Yan; David A Scott; Jonathan S Gootenberg; Andrea J Kriz; Bernd Zetsche; Ophir Shalem; Xuebing Wu; Kira S Makarova; Eugene V Koonin; Phillip A Sharp; Feng Zhang
Journal: Nature Date: 2015-04-01 Impact factor: 49.962

9. HBVdb: a knowledge database for Hepatitis B Virus.

Authors: Juliette Hayer; Fanny Jadeau; Gilbert Deléage; Alan Kay; Fabien Zoulim; Christophe Combet
Journal: Nucleic Acids Res Date: 2012-11-03 Impact factor: 16.971

10. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.

Authors: Hao Yin; Chun-Qing Song; Joseph R Dorkin; Lihua J Zhu; Yingxiang Li; Qiongqiong Wu; Angela Park; Junghoon Yang; Sneha Suresh; Aizhan Bizhanova; Ankit Gupta; Mehmet F Bolukbasi; Stephen Walsh; Roman L Bogorad; Guangping Gao; Zhiping Weng; Yizhou Dong; Victor Koteliansky; Scot A Wolfe; Robert Langer; Wen Xue; Daniel G Anderson
Journal: Nat Biotechnol Date: 2016-02-01 Impact factor: 54.908

84 in total

Review 1. Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities.

Authors: Ling Li; Shuo Hu; Xiaoyuan Chen
Journal: Biomaterials Date: 2018-04-18 Impact factor: 12.479

Review 2. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.

Authors: Piotr S Kowalski; Arnab Rudra; Lei Miao; Daniel G Anderson
Journal: Mol Ther Date: 2019-02-19 Impact factor: 11.454

Review 3. Transfection by cationic gemini lipids and surfactants.

Authors: M Damen; A J J Groenen; S F M van Dongen; R J M Nolte; B J Scholte; M C Feiters
Journal: Medchemcomm Date: 2018-07-17 Impact factor: 3.597

4. A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo.

Authors: Khalid A Hajj; Jilian R Melamed; Namit Chaudhary; Nicholas G Lamson; Rebecca L Ball; Saigopalakrishna S Yerneni; Kathryn A Whitehead
Journal: Nano Lett Date: 2020-06-09 Impact factor: 11.189

5. Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition.

Authors: Na Kong; Wei Tao; Xiang Ling; Junqing Wang; Yuling Xiao; Sanjun Shi; Xiaoyuan Ji; Aram Shajii; Silvia Tian Gan; Na Yoon Kim; Dan G Duda; Tian Xie; Omid C Farokhzad; Jinjun Shi
Journal: Sci Transl Med Date: 2019-12-18 Impact factor: 17.956

6. CRISPR-delivery particles targeting nuclear receptor-interacting protein 1 (Nrip1) in adipose cells to enhance energy expenditure.

Authors: Yuefei Shen; Jessica L Cohen; Sarah M Nicoloro; Mark Kelly; Batuhan Yenilmez; Felipe Henriques; Emmanouela Tsagkaraki; Yvonne J K Edwards; Xiaodi Hu; Randall H Friedline; Jason K Kim; Michael P Czech
Journal: J Biol Chem Date: 2018-09-06 Impact factor: 5.157